First clinical trial of new dapivirine ring with both anti-HIV drug and contraceptive finds ring is well-tolerated with no safety concerns

Sensitive ARV resistance tests detect no dapivirine-associated resistance among women using dapivirine vaginal ring in ASPIRE

Researchers present additional evidence on the safety of the dapivirine vaginal ring

Women’s use of vaginal ring is higher in open-label study, as is level of HIV protection

HIV prevention dapivirine vaginal ring found safe and acceptable in US adolescent girls

U.S. study of dapivirine ring in lactating women finds little drug gets into breast milk

MTN begins first trial of new dapivirine ring with both anti-HIV drug and contraceptive

International Study Finds High Levels of Adherence to Use of Rectal Microbicide Gel

Women facing intimate partner violence were less likely to use vaginal ring in ASPIRE

Dapivirine ring did not confer drug resistance among women who acquired HIV in ASPIRE